Executive Director, Pharmacokinetics and Clinical Pharmacology Ionis Pharmaceuticals Carlsbad, California
Join Dan Norris and several authors in Poster Forum #8 in the Solution Center for a conversation about posters on the topic, “PK Modeling Approaches for Non-traditional Routes and Modalities”, that he is especially excited about.
M1130-02-12 A Mechanistic Rat PBPK Model for Genistein and Its Glucuronide Metabolite: Integrating Liver and Enteric Metabolism with Transporter-Mediated Biliary and Enteroluminal Clearance, Bhargavi Srija Tamisetty, MS, University of Kansas
T1330-02-11 A PBPK Model for Acetaminophen: Incorporation of SULT Enzyme Ontogeny to Predict Age-Dependent Metabolism and Systemic Exposure in Pediatric Patient Populations, David R. Taft, Ph.D., Long Island University
T1030-02-07 Pediatric Oral Cavity PBPK Model to Predict Pharmacokinetics of Mucoadhesive Atropine Gel to Treat Sialorrhea, Madison Parrot, BS, University of Utah
W0930-02-08 Lumbar Intrathecal Infusion of an siRNA Formulation via Cannulation in Rats Demonstrated Comparable Tissue Distributions and Improved Animal Response as Comparing to Non-Cannulated Free Hand Method, Viola Wang, Ph.D., WuXi AppTec Co., Ltd.
T0930-02-12 A PBPK Model to Simulate Intranasal Naloxone Rescue from Fentanyl Overdose, Robert A. Bellantone, Ph.D., Physical Pharmaceutica, LLC
